CN112335879A - 一种海红米皮制的控糖益生元及其制造方法 - Google Patents
一种海红米皮制的控糖益生元及其制造方法 Download PDFInfo
- Publication number
- CN112335879A CN112335879A CN201910716494.6A CN201910716494A CN112335879A CN 112335879 A CN112335879 A CN 112335879A CN 201910716494 A CN201910716494 A CN 201910716494A CN 112335879 A CN112335879 A CN 112335879A
- Authority
- CN
- China
- Prior art keywords
- sugar
- controlling
- parts
- prebiotics
- red rice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013406 prebiotics Nutrition 0.000 title claims abstract description 9
- 238000002360 preparation method Methods 0.000 title abstract description 6
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 title abstract description 3
- 240000007594 Oryza sativa Species 0.000 claims abstract description 15
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 15
- 235000007189 Oryza longistaminata Nutrition 0.000 claims abstract description 12
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 11
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 9
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 9
- 239000000843 powder Substances 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 235000009566 rice Nutrition 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 241000233866 Fungi Species 0.000 claims 1
- 244000248825 Peltandra virginica Species 0.000 claims 1
- 235000001188 Peltandra virginica Nutrition 0.000 claims 1
- 235000008599 Poria cocos Nutrition 0.000 claims 1
- 244000046146 Pueraria lobata Species 0.000 claims 1
- 235000010575 Pueraria lobata Nutrition 0.000 claims 1
- 241001506047 Tremella Species 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 11
- 235000016709 nutrition Nutrition 0.000 abstract description 10
- 235000013305 food Nutrition 0.000 abstract description 6
- 235000013402 health food Nutrition 0.000 abstract description 6
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 239000002131 composite material Substances 0.000 abstract description 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract description 3
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 12
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 102000004877 Insulin Human genes 0.000 description 6
- 108090001061 Insulin Proteins 0.000 description 6
- 229940125396 insulin Drugs 0.000 description 6
- 235000012054 meals Nutrition 0.000 description 6
- 235000013325 dietary fiber Nutrition 0.000 description 5
- 239000006041 probiotic Substances 0.000 description 5
- 235000018291 probiotics Nutrition 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 206010013663 drug dependence Diseases 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000008821 health effect Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 230000000291 postprandial effect Effects 0.000 description 2
- 230000001603 reducing effect Effects 0.000 description 2
- 208000011117 substance-related disease Diseases 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 206010018429 Glucose tolerance impaired Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 208000001280 Prediabetic State Diseases 0.000 description 1
- 241000245165 Rhododendron ponticum Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 230000009693 chronic damage Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 201000009104 prediabetes syndrome Diseases 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种保健食品，特别公开了一种海红米皮制的控糖益生元及其制造方法。该食物其特殊之处在于：包括如下重量份数的原料：海红米皮4份、灭活食用酵母粉1份、低聚果糖1份。本发明特别对糖尿病，尤其二型糖尿病治疗效果较佳。也是绿色营养保健食品，既能满足人们日常的营养价值需要，又无毒副作用。
Description
一)技术领域
本发明涉及一种保健食品，特别涉及一种海红米皮制的控糖益生元及其制造方法。
二)背景技术
糖尿病仍是一种可以控制但不能根治的疾病，而饮食和运动是糖尿病治疗的基础。
胰岛素几乎是人体内惟一的降糖激素，而糖尿病患者都有不同程度的胰岛素不足，这就导
致人体血糖升高。如果摄取的食物过多，餐后血糖就会陡然上升，给本来已经疲惫的胰岛
β细胞增加负担。而且部分由于肥胖导致胰岛素抵抗的患者本身对胰岛素不敏感，如果他
们摄取的食物过多，体重持续增加，对糖尿病病情无疑雪上加霜。所以，糖尿病患者在任
何时间都必须坚持糖尿病的饮食治疗。
糖尿病时长期存在的高血糖，导致各种组织，特别是眼、肾、心脏、血管、神经的
慢性损害、功能障碍。
大多数糖尿病患者对药物具有依赖性，需要终身服药，但药物的毒副作用，会对人
的身体造成另外的伤害，诱发各种并发症。
三)发明内容
本发明为了弥补现有技术的不足，提供了一种无毒副作用、营养价值高一种海红米
皮制的控糖益生元及其制造方法。
本发明是通过如下技术方案实现的：
一种海红米皮制的控糖益生元，其特殊之处在于：包括如下重量份数的原料：
海红米皮 4 份;
灭活食用酵母粉 0.5 份;
低聚果糖 0.5 份;
本发明的一种海红米皮制的控糖益生元的制造方法，其特殊之处在于：
(1) 海红米皮 4 份用 200目粉碎机粉碎;
(2)将粉碎后的海红米皮和灭活食用酵母粉 0.5份、低聚果糖粉 0.5 份搅拌均匀，
(3)装入密封容器（防止受潮），
(4)容器放进蒸汽灭菌炉高温高压灭菌（120摄氏度 30分钟），自然冷却至常温，分
装入袋。
食用方法：每袋 5 克，每日两次，每次一袋，餐后用 40℃以下温水冲服。
糖尿病病人连续食用三个月，可减少用药，无毒副作用，可长期食用。
海红米皮：含高量维生素、膳食纤维、氨基酸及矿物质等。有研究表明，微量元素
锌铬硒有降糖降脂的作用。成分检测报告如下：
灭活食用酵母粉：属于即食酵母，是专门为人体补充营养而培养的一种酵母，是一
种健康营养的食品，与其他的酵母相比，它的维生素配比更加科学，含 B族维生素，提供
益生菌成长的空间，维持血管的弹性，进而协助血液循环正常运作，另外还富含大量优质
膳食纤维，吸水膨胀后可以吸附脂肪，它可携带着吃进胃肠的脂肪滴从大便中排出，从而
减少脂肪的吸收，能够满足人体的营养需求。
低聚果糖：是一种水溶性膳食纤维，长期服用可以降低血清胆固醇，改善脂质代谢，
另外它不能被人体直接消化吸收，只能被肠道细菌吸收利用，故其热值低，不会导致肥胖，
间接也有减肥作用，对糖尿病患者来说也是一种良好的甜味剂。
根据人体的免疫平衡等机理优选配伍制成的保健食品，其保健功效不但大于各组分
相加之和，其协同增强作用显著提高，具有单一组分和同类复合组分所不能达到的意外保
健功效。
功效：该食品含有膳食纤维和低聚果糖，膳食纤维能直接影响体内葡萄糖吸收，有
助于肠道益生菌的生长，减慢身体对葡萄糖的吸收。低聚果糖可促进益生菌的生长，灭活
食用酵母可增加体内对胰岛素的敏感性，有助于人体降低血糖浓度,抑制前期糖尿病的症状，
促进糖尿病的康复。
本发明特别对二型糖尿病患者治疗效果较佳，也是绿色营养保健食品，既能满足人
们日常的营养价值需要，又无毒副作用。
每日两次，每袋 5 克，每次一袋，餐后用 40℃以下温水冲服。
糖尿病病人连续食用三个月，可减少用药，无毒副作用，可长期食用。经非胰岛素
依赖型糖尿病人对本发明的营养餐进行口服试验，结果是服用 1-3 个月后，可降低餐后血
糖 50-260毫克/100毫升，与原餐后血糖值比降低 35-50％。
四)具体实施方式
实施例 1：
该以海红米皮提取物为主要原料的控糖益生元的制造方法，包括如下步骤：
(1) 海红米皮 4份用 200 目粉碎机粉碎，与灭活食用酵母粉 1份、低聚果糖 1份搅拌均匀，
装入密封容器（防止受潮），放进蒸汽灭菌炉高温高压灭菌（120摄氏度 30分钟），自然冷
却至常温，分装入袋。
实施例 2：
该糖尿病人营养餐，由如下重量份数的原料制成：海红米皮 3.5份用 200目粉碎机粉碎，与灭活食用酵母粉 1份、低聚果糖 0.5份。
Claims (1)
1. 一种海红米皮制的控糖益生元及其制造方法，其特征在于：原料为：红米 20 份、茯苓 1 份、葛根 1 份、银耳 1 份、黑木耳 1 份；该方法具体包括如下步骤：
(1) 海红米皮 4 份用 200 目粉碎机粉碎，
(2)将粉碎后的海红米皮和灭活食用酵母粉 0.5份、低聚果糖粉 0.5份搅拌均匀，
(3)装入密封容器（防止受潮），
(4)容器放进蒸汽灭菌炉高温高压灭菌（120摄氏度 30 分钟），自然冷却至常温，分装入袋。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910716494.6A CN112335879A (zh) | 2019-08-07 | 2019-08-07 | 一种海红米皮制的控糖益生元及其制造方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910716494.6A CN112335879A (zh) | 2019-08-07 | 2019-08-07 | 一种海红米皮制的控糖益生元及其制造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112335879A true CN112335879A (zh) | 2021-02-09 |
Family
ID=74366248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910716494.6A Pending CN112335879A (zh) | 2019-08-07 | 2019-08-07 | 一种海红米皮制的控糖益生元及其制造方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112335879A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111956744A (zh) * | 2020-03-06 | 2020-11-20 | 广东海洋大学 | 海红米皮在制备抗快感缺乏行为的药物中的应用 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001033976A1 (en) * | 1999-11-08 | 2001-05-17 | Childrens Hospital Los Angeles Research Institute | Methods for regulating blood glucose and appetite suppression in type 2 diabetics |
| CN101190007A (zh) * | 2007-03-19 | 2008-06-04 | 舟山市红宝食疗研究所 | 含有米麸的营养食品 |
| CN101606694A (zh) * | 2008-06-19 | 2009-12-23 | 刘泳宏 | 一种天然五色降脂降糖降压粥及制作方法 |
| CN103876138A (zh) * | 2014-03-14 | 2014-06-25 | 德阳市荞老头食品有限公司 | 一种适合糖尿病人的苦荞生活食品 |
| CN107087781A (zh) * | 2017-06-20 | 2017-08-25 | 慧谷生命科技湖北有限公司 | 一种适用于糖尿病的芡实葛根代餐粉 |
-
2019
- 2019-08-07 CN CN201910716494.6A patent/CN112335879A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001033976A1 (en) * | 1999-11-08 | 2001-05-17 | Childrens Hospital Los Angeles Research Institute | Methods for regulating blood glucose and appetite suppression in type 2 diabetics |
| CN101190007A (zh) * | 2007-03-19 | 2008-06-04 | 舟山市红宝食疗研究所 | 含有米麸的营养食品 |
| CN101606694A (zh) * | 2008-06-19 | 2009-12-23 | 刘泳宏 | 一种天然五色降脂降糖降压粥及制作方法 |
| CN103876138A (zh) * | 2014-03-14 | 2014-06-25 | 德阳市荞老头食品有限公司 | 一种适合糖尿病人的苦荞生活食品 |
| CN107087781A (zh) * | 2017-06-20 | 2017-08-25 | 慧谷生命科技湖北有限公司 | 一种适用于糖尿病的芡实葛根代餐粉 |
Non-Patent Citations (1)
| Title |
|---|
| 胡柏等: "红米多酚对体外碳水化合物消化和吸收的影响", 《现代食品科技》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111956744A (zh) * | 2020-03-06 | 2020-11-20 | 广东海洋大学 | 海红米皮在制备抗快感缺乏行为的药物中的应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108112996B (zh) | 一种控制2型糖尿病人群高血糖和提高免疫力的营养组合物 | |
| CN103238897B (zh) | 一种适用于糖尿病人的复合植物固体饮料 | |
| CN101496579B (zh) | 一种供肿瘤患者食用含短肽的特殊膳食用食品配方 | |
| CN102813113B (zh) | 一种能调节人体菌群和免疫功能的组合物 | |
| CN106174585A (zh) | 降血糖的组合物及降血糖的复合益生菌特膳食品 | |
| CN101564161B (zh) | 高血脂高血糖患者专用的营养保健食品及其制备方法 | |
| CN102113648A (zh) | 一种适合“五高”代谢综合症人群的特膳面条及其制备方法 | |
| CN106135797A (zh) | 一种有助于调节血糖的营养组合物及其制备方法 | |
| CN104605353A (zh) | 适用于手术后肿瘤患者食用的配方食品及其制备方法 | |
| CN105148252A (zh) | 一种复方降糖制剂 | |
| CN108391785A (zh) | 一种功能性代餐粉及其制作工艺与应用 | |
| CN107212256A (zh) | 一种具有降血糖功能的代餐粉及其制备方法 | |
| CN104855994A (zh) | 肾病非全营养配方食品 | |
| CN102113652A (zh) | 一种适合“五高”代谢综合症人群的特膳挤压米及其制备方法 | |
| CN106993788A (zh) | 全天然蜂王浆含片及其制备方法 | |
| CN105661547A (zh) | 一种益生菌复配蚕桑的糖尿病人营养补充剂 | |
| CN109170863A (zh) | 一种功能糖酵素及其制备方法 | |
| CN112335879A (zh) | 一种海红米皮制的控糖益生元及其制造方法 | |
| CN107802770A (zh) | 平衡代谢系统根治早期ⅱ型糖尿病的中药和保健品 | |
| CN102204650B (zh) | 一种低血糖指数保健主食及其制备方法与降血糖应用 | |
| CN109043555A (zh) | 一种高血糖患者食用的特殊食品及其制备方法 | |
| CN109393466A (zh) | 一种素食粉 | |
| CN114532544A (zh) | 降糖、控糖的谷果植物肽固体饮料 | |
| JP6167357B1 (ja) | 糖尿病の改善予防剤 | |
| CN104304487A (zh) | 具有降血糖功效的保健牛奶及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210209 |
|
| RJ01 | Rejection of invention patent application after publication |